HSP90AA1 and cancer: Gong et al. have shown that metformin, a drug against type 2 diabetes, can suppress such an EMT/cancer stemness-associated phenomenon as metastasis occurrence by inhibiting HSP90α secretion in a phosphorylation-dependent manner involving AMP-activated protein kinase α1 and protein kinase Cγ [109].